In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

FOXBORO – Hiring Mike Vrabel to be the next head coach of the New England Patriots was a no-brainer. Even if you take the events of 2024 out of the equation, Vrabel is still the right choice. He ...

Those include Fibrogen's pamrevlumab and Roche's PRM-151 in phase 3 – as well as Novartis' ianalumab, Galecto Biotech's TD-139/, Bristol-Myers Squibb's CC-90001 and BMS-986278, and Liminal ...

The Dallas Cowboys' search for the franchise's next head coach is underway. On Monday, longtime Cowboys owner and general manager Jerry Jones confirmed that the organization and coach Mike ...

The Post welcomes letters up to 250 words on topics of general interest. Letters must include full name, home address, day and evening phone numbers, and may be edited for length, grammar and ...

Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche (ROG: SIX) has exercised its option to license a novel capsid ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...